ROK
71
3
MO
44
2
K
45
3
DNB
58
2
FTI
61
-5
APA
31
-3
DOV
52
2
HES
54
-2
MMC
50
2
FSLR
44
-6
SPG
41
3
VMC
60
-2
TMO
44
-2
STI
35
-5
EQR
37
3
NTRS
64
15
RHI
27
2
ICE
52
2
PEG
39
2
BF.B
46
2
ROK
71
3
MO
44
2
K
45
3
DNB
58
2
FTI
61
-5
APA
31
-3
DOV
52
2
HES
54
-2
MMC
50
2
FSLR
44
-6
SPG
41
3
VMC
60
-2
TMO
44
-2
STI
35
-5
EQR
37
3
NTRS
64
15
RHI
27
2
ICE
52
2
PEG
39
2
BF.B
46
2
Financhill
Back

Nuveen Quality Municipal Income Fund Vs. United Therapeutics Industry Stock Comparison

Sell
25

NAD
Nuveen Quality Municipal Income Fund

Last Price:
$11.11
Seasonality Move:
-0.05%
Sell
49

UTHR
United Therapeutics

Last Price:
$297.44
Seasonality Move:
7.07%
Sell
25
Nuveen Quality Municipal Income Fund (NAD) is a Sell

Is Nuveen Quality Municipal Income Fund a Buy, Sell or Hold?

  • The current Nuveen Quality Municipal Income Fund [NAD] share price is $11.18. The Score for NAD is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • NAD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
United Therapeutics (UTHR) is a Sell

Is United Therapeutics a Buy, Sell or Hold?

  • The current United Therapeutics [UTHR] share price is $298.16. The Score for UTHR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • UTHR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NAD Stock Price Chart

What is Nuveen Quality Municipal Income Fund's stock price today?

  • The Nuveen Quality Municipal Income Fund share price today is $11.18
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NAD is experiencing selling pressure, which indicates risk of future bearish movement.

UTHR Stock Price Chart

What is United Therapeutics's stock price today?

  • The United Therapeutics share price today is $298.16
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing slight buying pressure.

NAD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.08 Buy
Relative Strength Index (14 RSI): 40.29 Sell
Chaikin Money Flow: -612323 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.18 - 11.36) Sell
Bollinger Bands (100): (11.1 - 11.62) Sell

UTHR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 81.01 Buy
Relative Strength Index (14 RSI): 52.16 Buy
Chaikin Money Flow: 99734 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (284.21 - 296.11) Buy
Bollinger Bands (100): (286.32 - 322.46) Sell

NAD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.34 Sell
20-day SMA: 11.28 Sell
50-day SMA: 11.26 Sell
200-day SMA: 11.66 Sell
8-day EMA: 9.35 Buy
20-day EMA: 5.7 Buy
50-day EMA: 2.77 Buy
200-day EMA: 0.77 Buy

UTHR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 296.27 Buy
20-day SMA: 291.91 Buy
50-day SMA: 301 Sell
200-day SMA: 334.81 Sell
8-day EMA: 245.76 Buy
20-day EMA: 149.61 Buy
50-day EMA: 72.56 Buy
200-day EMA: 20.09 Buy

Nuveen Quality Municipal Income Fund Earnings Growth & NAD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

United Therapeutics Earnings Growth & UTHR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.78 per share, an increase next quarter of $0.76 per share, an increase this year of $2.42 per share, and an increase next year of $1.34 per share.

Nuveen Quality Municipal Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

United Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):